Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in Patients With Schizophrenia

NCT00088491 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1205

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenic Disorders

Interventions

DRUG: Intramuscular Olanzapine Depot
DRUG: Oral Olanzapine

Sponsor

Eli Lilly and Company